Sunday , October 22 2017
Home / Resources / Clinical Presentations / Cost-Effectiveness Strategies, Part 4 of 4

Cost-Effectiveness Strategies, Part 4 of 4

DCMS28_HS_Image

A pooled analysis of the data from the 3 pivotal trials showed reductions in A1C and LDL-C when Welchol was added to metformin-based, sulfonylurea-based, and insulin-based therapies in patients with type 2 diabetes. In these studies….

Link to download (.ppt format): Cost-Effectiveness Strategies, Part 4 of 4

 

Other sets in this series:

Cost-Effectiveness Strategies, Part 1 of 4

Cost-Effectiveness Strategies, Part 2 of 4

Cost-Effectiveness Strategies, Part 3 of 4

 

Check out all of Diabetes In Control’s slide collections at our new Clinical Presentations Library.